ArticleJCO precision oncology2026

Developing a Metabolic-Associated Prognostic Index for Risk Stratification and Therapeutic Guidance in Stage I Lung Adenocarcinoma via Multiomics Analysis.

Pengcheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.